potential of missing data or bias), and little attention to patients with advanced disease who received opioids for pain management rather than as a perioperative anesthetic. To provide a better assessment of the impact of opioid use on outcomes of patients
Search Results
Omar Abdel-Rahman, Hatim Karachiwala, and Jacob C. Easaw
Jessica D. McDermott, Megan Eguchi, Rustain Morgan, Arya Amini, Julie A. Goddard, Evelinn A. Borrayo, and Sana D. Karam
Background Approximately 65,000 new cases of head and neck cancer (HNC) are diagnosed in the United States annually, with 13,500 cancer-related deaths. 1 HNC has discrepancies in presentations and outcomes across different racial and ethnic cohorts
Joseph A. Greer, Beverly Moy, Areej El-Jawahri, Vicki A. Jackson, Mihir Kamdar, Juliet Jacobsen, Charlotta Lindvall, Jennifer A. Shin, Simone Rinaldi, Heather A. Carlson, Angela Sousa, Emily R. Gallagher, Zhigang Li, Samantha Moran, Magaret Ruddy, Maya V. Anand, Julia E. Carp, and Jennifer S. Temel
/caregiver or oncologist. When these patients received PC, they did not follow the intervention protocol. Study Measures Documentation of EoL Care Preferences (Primary Outcome) To identify clinician documentation of EoL care discussions, we used
Luke R.G. Pike, Trevor J. Royce, Amandeep R. Mahal, Daniel W. Kim, William L. Hwang, Brandon A. Mahal, and Nina N. Sanford
higher smoking rates in these populations. 7 , 14 Furthermore, the inferior outcomes observed in patients of lower socioeconomic status (SES) with SCCHN have largely been attributed to a predominance of HPV-negative disease. 7 , 14 However, these
Meagan S. Whisenant, Faith A. Strunk, Debasish Tripathy, and Loretta A. Williams
Background: The use of disease-specific patient-reported outcomes (PROs) is critical for facilitating individualized symptom monitoring and improving cancer patient outcomes. The MD Anderson Symptom Inventory (MDASI) is a PRO measure of symptom
Victoria Crossland, Aaron Galaznik, Huamao M. Lin, Dimitrios Tomaras, Shan Ashton Garib, Shuanglian Li, Hui Huang, and Anna Forsythe
and outcome data for the uncommon EGFR exon 20 insertion mutation. Methods: An SLR was performed on August 7, 2018 following the Preferred Reporting Item for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, using the Population, Intervention
Nirmala K. Manjappachar, John A. Cuenca, Claudia M. Ramírez, Mike Hernandez, Peyton Martin, Maria P. Reyes, Alba J. Heatter, Cristina Gutierrez, Nisha Rathi, Charles L. Sprung, Kristen J. Price, and Joseph L. Nates
included small cohorts or were spread over long periods, leading to time bias. 5 , 15 , 16 In other studies, severe sepsis and septic shock are reported together. 5 , 14 This article reports on the short-term outcomes and the independent predictors of 28
Ronald Chow, Daniel E. Lage, Grant R. Williams, Mina S. Sedrak, Joseph A. Greer, Jennifer S. Temel, and Ryan D. Nipp
that older adults represent less than one-third of cancer clinical trial participants. Moreover, according to a recent meta-analysis of >150 clinical trials, only between 40% and 70% of clinical trials reported on the outcomes of older adult subgroups
Nivedita Arora, Arjun Gupta, Hong Zhu, Alana Christie, Jeffrey J. Meyer, Saad A. Khan, and Muhammad S. Beg
(RT) considered first-line therapy, and salvage surgery used for resistant or recurrent disease. 8 Race and sex disparities related to access to care and outcomes have been studied for several malignancies, including pancreatic, breast, and lung
Claudia S.E.W. Schuurhuizen, Annemarie M.J. Braamse, Aartjan T.F. Beekman, Pim Cuijpers, Mecheline H.M. van der Linden, Adriaan W. Hoogendoorn, Hans Berkhof, Dirkje W. Sommeijer, Vera Lustig, Suzan Vrijaldenhoven, Haiko J. Bloemendal, Cees J. van Groeningen, Annette A. van Zweeden, Maurice J.D.L. van der Vorst, Ron Rietbroek, Cathrien S. Tromp-van Driel, Machteld N.W. Wymenga, Peter W. van der Linden, Aart Beeker, Marco B. Polee, Erdogan Batman, Maartje Los, Aart van Bochove, Jan A.C. Brakenhoff, Inge R.H.M. Konings, Henk M.W. Verheul, and Joost Dekker
interventions and social support for patients with diagnosed distress have been shown to be effective, 7 – 11 but so far no conclusive evidence shows that the combination of screening and subsequent treatment of distress actually improves patient outcomes
